Last reviewed · How we verify
NCT07061600
Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media
NA trial testing "ich bin alles" in Depressive Disorder in 170 participants. Completed in 22 October 2025.
22 October 2025
Quick facts
| Lead sponsor | Ludwig-Maximilians - University of Munich |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 170 |
| Start date | 1 April 2025 |
| Primary completion | 22 October 2025 |
| Estimated completion | 22 October 2025 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- "ich bin alles"
- Instagram profile that provides educational content
Conditions studied
- Depressive Disorder — all drugs for Depressive Disorder →
- Depression - Major Depressive Disorder — all drugs for Depression - Major Depressive Disorder →
- Depression in Adolescence — all drugs for Depression in Adolescence →
Sponsor
Ludwig-Maximilians - University of Munich
Who can join
Adults 13 to 18, any sex, with Depressive Disorder or Depression - Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Depression is a highly common mental disorder that often begins in adolescence. Despite its high burden and negative consequences, few young people seek professional help due to, e.g., low mental health literacy and fear of stigma. Since adolescents frequently seek health information online and use social media daily, the project "ich bin alles" (English: "I am everything"; www.ich-bin-alles.de) was launched to provide easily accessible, age-appropriate, and evidence-based information about depression and mental health via digital platforms including a website and social media channels (e.g., Instagram). This study aims to evaluate the effectiveness of the "ich bin alles"- Instagram channel in improving depression literacy, reducing stigma, and encouraging help-seeking behavior, as well as assessing user acceptance and content reception.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07061600
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depressive Disorder
Currently open trials in the same condition.
- NCT07290153 — Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC · recruiting
- NCT07100951 — Comparing Brief Psychoanalytic Couple Therapy and Emotionally Focused Therapy in Reducing Relationship Distress · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06901739 — Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity. · NA · recruiting
- NCT06724666 — Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression · NA · recruiting
Other Ludwig-Maximilians - University of Munich trials
Trials by the same sponsor.
- NCT07514520 — Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION · active not recruiting
- NCT07504965 — Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly · recruiting
- NCT07100548 — A Qualitative Analysis of Youth Responses to Depression Education Delivered on Social Media · completed
- NCT06749106 — Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage · recruiting
- NCT07336199 — Pairing Subjective Patient Rating and DBS Programming · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07061600 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ludwig-Maximilians - University of Munich
- Last refreshed: 4 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07061600.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing